MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients

PURPOSE: Determining the optimal strategy to implement systemic treatment modalities has been challenging in triple-negative breast cancer (TNBC). We aim to investigate the role of microRNA-223 (miR-223) as prognostic factor and predictor of response toward chemotherapy in TNBC. PATIENTS AND METHODS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer (Dove Med Press)
Hlavní autoři: Purwanto, Ibnu, Heriyanto, Didik Setyo, Widodo, Irianiwati, Hakimi, Mohammad, Hardianti, Mardiah Suci, Aryandono, Teguh, Haryana, Sofia Mubarika
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797287/
https://ncbi.nlm.nih.gov/pubmed/33442288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S291014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky